Prostate Cancer Diagnostics Market Report

Europe Prostate Cancer Diagnostics Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 21, 2020
  • PAGES：213
  • REPORT CODE：GMM571155
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Prostate Cancer Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Prostate Cancer Diagnostics Market Segmentations:

    By Player:

    • Myriad Genetics

    • Ambry Genetics

    • Abbott

    • OPKO

    • DiaSorin

    • Beckman Coulter

    • bioMeriux

    • Siemens Healthcare

    • Roche

    • Genomic Health

    • MDx Health

    By Type:

    • Tumor Biomarker Tests

    • Imaging

    • Biopsy

    • Others

    By End-User:

    • < 55

    • 55-75

    • > 75

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate Cancer Diagnostics Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Prostate Cancer Diagnostics Market Size and Growth Rate of Tumor Biomarker Tests from 2014 to 2026

    • 1.3.2 Europe Prostate Cancer Diagnostics Market Size and Growth Rate of Imaging from 2014 to 2026

    • 1.3.3 Europe Prostate Cancer Diagnostics Market Size and Growth Rate of Biopsy from 2014 to 2026

    • 1.3.4 Europe Prostate Cancer Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Prostate Cancer Diagnostics Market Size and Growth Rate of < 55 from 2014 to 2026

    • 1.4.2 Europe Prostate Cancer Diagnostics Market Size and Growth Rate of 55-75 from 2014 to 2026

    • 1.4.3 Europe Prostate Cancer Diagnostics Market Size and Growth Rate of > 75 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prostate Cancer Diagnostics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prostate Cancer Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Tumor Biomarker Tests

      • 3.4.2 Market Size and Growth Rate of Imaging

      • 3.4.3 Market Size and Growth Rate of Biopsy

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Prostate Cancer Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prostate Cancer Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of < 55 for Construction

      • 4.4.2 Market Size and Growth Rate of 55-75 for Construction

      • 4.4.3 Market Size and Growth Rate of > 75 for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Prostate Cancer Diagnostics Production Analysis by Top Regions

    • 5.2 Europe Prostate Cancer Diagnostics Consumption Analysis by Top Regions

    • 5.3 Europe Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.3 France Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    6 Product Circulation of Prostate Cancer Diagnostics Market among Top Countries

    • 6.1 Top 5 Export Countries in Prostate Cancer Diagnostics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Prostate Cancer Diagnostics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Prostate Cancer Diagnostics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Prostate Cancer Diagnostics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Prostate Cancer Diagnostics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Prostate Cancer Diagnostics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Prostate Cancer Diagnostics Landscape Analysis

    • 7.1 Germany Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 7.2 Germany Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    8. UK Prostate Cancer Diagnostics Landscape Analysis

    • 8.1 UK Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 8.2 UK Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    9. France Prostate Cancer Diagnostics Landscape Analysis

    • 9.1 France Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 9.2 France Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    10. Italy Prostate Cancer Diagnostics Landscape Analysis

    • 10.1 Italy Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 10.2 Italy Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    11. Spain Prostate Cancer Diagnostics Landscape Analysis

    • 11.1 Spain Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 11.2 Spain Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    12. Poland Prostate Cancer Diagnostics Landscape Analysis

    • 12.1 Poland Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 12.2 Poland Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    13. Russia Prostate Cancer Diagnostics Landscape Analysis

    • 13.1 Russia Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 13.2 Russia Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    14. Switzerland Prostate Cancer Diagnostics Landscape Analysis

    • 14.1 Switzerland Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 14.2 Switzerland Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    15. Turkey Prostate Cancer Diagnostics Landscape Analysis

    • 15.1 Turkey Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 15.2 Turkey Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Landscape Analysis by Top Countries

      • 16.3.1 Denmark Prostate Cancer Diagnostics Market Volume and Growth Rate

      • 16.3.2 Finland Prostate Cancer Diagnostics Market Volume and Growth Rate

      • 16.3.3 Norway Prostate Cancer Diagnostics Market Volume and Growth Rate

      • 16.3.4 Sweden Prostate Cancer Diagnostics Market Volume and Growth Rate

      • 16.3.6 Iceland Prostate Cancer Diagnostics Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Landscape Analysis by Top Countries

      • 17.3.1 Belgium Prostate Cancer Diagnostics Market Volume and Growth Rate

      • 17.3.2 Netherlands Prostate Cancer Diagnostics Market Volume and Growth Rate

      • 17.3.3 Luxembourg Prostate Cancer Diagnostics Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Landscape Analysis by Top Countries

      • 18.3.1 Estonia Prostate Cancer Diagnostics Market Volume and Growth Rate

      • 18.3.2 Latvia Prostate Cancer Diagnostics Market Volume and Growth Rate

      • 18.3.3 Lithuania Prostate Cancer Diagnostics Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Myriad Genetics

      • 19.1.1 Myriad Genetics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Ambry Genetics

      • 19.2.1 Ambry Genetics Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Abbott

      • 19.3.1 Abbott Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 OPKO

      • 19.4.1 OPKO Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 DiaSorin

      • 19.5.1 DiaSorin Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Beckman Coulter

      • 19.6.1 Beckman Coulter Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 bioMeriux

      • 19.7.1 bioMeriux Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Siemens Healthcare

      • 19.8.1 Siemens Healthcare Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Roche

      • 19.9.1 Roche Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Genomic Health

      • 19.10.1 Genomic Health Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 MDx Health

      • 19.11.1 MDx Health Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    The List of Tables and Figures (Totals 120 Figures and 146 Tables)

    • Figure Product Picture

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of Tumor Biomarker Tests Market, 2015 - 2026 (USD Million)

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of Imaging Market, 2015 - 2026 (USD Million)

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of Biopsy Market, 2015 - 2026 (USD Million)

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of < 55 from 2014 to 2026

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of 55-75 from 2014 to 2026

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of > 75 from 2014 to 2026

    • Figure Germany Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure UK Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure France Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Prostate Cancer Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prostate Cancer Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prostate Cancer Diagnostics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prostate Cancer Diagnostics by Different Types from 2014 to 2026

    • Table Consumption Share of Prostate Cancer Diagnostics by Different Types from 2014 to 2026

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of Tumor Biomarker Tests Market, 2015 - 2026 (USD Million)

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of Imaging Market, 2015 - 2026 (USD Million)

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of Biopsy Market, 2015 - 2026 (USD Million)

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prostate Cancer Diagnostics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prostate Cancer Diagnostics by Different End-Users from 2014 to 2026

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of < 55 from 2014 to 2026

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of 55-75 from 2014 to 2026

    • Figure Prostate Cancer Diagnostics Market Size and Growth Rate of > 75 from 2014 to 2026

    • Table Europe Prostate Cancer Diagnostics Production by Major Regions

    • Table Europe Prostate Cancer Diagnostics Production Share by Major Regions

    • Figure Europe Prostate Cancer Diagnostics Production Share by Major Countries and Regions in 2014

    • Table Europe Prostate Cancer Diagnostics Consumption by Major Regions

    • Table Europe Prostate Cancer Diagnostics Consumption Share by Major Regions

    • Table Germany Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table UK Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table France Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Italy Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Spain Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Poland Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Russia Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Switzerland Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Turkey Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Prostate Cancer Diagnostics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Prostate Cancer Diagnostics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Prostate Cancer Diagnostics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Prostate Cancer Diagnostics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Germany Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Germany Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Germany Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table UK Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table UK Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table UK Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table UK Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table France Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table France Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table France Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table France Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Italy Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Italy Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Italy Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Italy Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Spain Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Spain Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Spain Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Spain Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Poland Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Poland Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Poland Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Poland Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Russia Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Russia Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Russia Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Russia Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Switzerland Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Switzerland Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Switzerland Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Turkey Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Turkey Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Turkey Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Prostate Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Myriad Genetics Profiles

    • Table Myriad Genetics Production, Value, Price, Gross Margin 2014-2019

    • Table Myriad Genetics Product benchmarking

    • Table Myriad Genetics Strategic initiatives

    • Table Myriad Genetics SWOT analysis

    • Table Ambry Genetics Profiles

    • Table Ambry Genetics Production, Value, Price, Gross Margin 2014-2019

    • Table Ambry Genetics Product benchmarking

    • Table Ambry Genetics Strategic initiatives

    • Table Ambry Genetics SWOT analysis

    • Table Abbott Profiles

    • Table Abbott Production, Value, Price, Gross Margin 2014-2019

    • Table Abbott Product benchmarking

    • Table Abbott Strategic initiatives

    • Table Abbott SWOT analysis

    • Table OPKO Profiles

    • Table OPKO Production, Value, Price, Gross Margin 2014-2019

    • Table OPKO Product benchmarking

    • Table OPKO Strategic initiatives

    • Table OPKO SWOT analysis

    • Table DiaSorin Profiles

    • Table DiaSorin Production, Value, Price, Gross Margin 2014-2019

    • Table DiaSorin Product benchmarking

    • Table DiaSorin Strategic initiatives

    • Table DiaSorin SWOT analysis

    • Table Beckman Coulter Profiles

    • Table Beckman Coulter Production, Value, Price, Gross Margin 2014-2019

    • Table Beckman Coulter Product benchmarking

    • Table Beckman Coulter Strategic initiatives

    • Table Beckman Coulter SWOT analysis

    • Table bioMeriux Profiles

    • Table bioMeriux Production, Value, Price, Gross Margin 2014-2019

    • Table bioMeriux Product benchmarking

    • Table bioMeriux Strategic initiatives

    • Table bioMeriux SWOT analysis

    • Table Siemens Healthcare Profiles

    • Table Siemens Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Siemens Healthcare Product benchmarking

    • Table Siemens Healthcare Strategic initiatives

    • Table Siemens Healthcare SWOT analysis

    • Table Roche Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Roche Product benchmarking

    • Table Roche Strategic initiatives

    • Table Roche SWOT analysis

    • Table Genomic Health Profiles

    • Table Genomic Health Production, Value, Price, Gross Margin 2014-2019

    • Table Genomic Health Product benchmarking

    • Table Genomic Health Strategic initiatives

    • Table Genomic Health SWOT analysis

    • Table MDx Health Profiles

    • Table MDx Health Production, Value, Price, Gross Margin 2014-2019

    • Table MDx Health Product benchmarking

    • Table MDx Health Strategic initiatives

    • Table MDx Health SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US